Health Information Portal (HIP)

0 results

No results, please enter a search term above


View Previous Years

The Philadelphia Department of Public Health's Division of Disease Control collects, manages, and analyzes data on active Tuberculosis disease (TB), LTBI, and other infections caused by mycobacteria related to Mycobacterium tuberculosis. Data collected include, but are not limited to, demographic, diagnostic, and surveillance-specific disease characteristics (e.g. drug resistance). Accurate identification and timely reporting of both tuberculosis disease and infection are critical to successful treatment of patients and control of the spread of TB infection. Successful TB surveillance allows PDPH to:

  • Provide Directly Observed Therapy (DOT), which is the preferred standard of care for patients with active tuberculosis;
  • Identify contacts who may be infected or at risk of infection to offer preventive therapy;
  • Assist healthcare providers in identifying, evaluating, and managing TB patients (through Self Administered Therapy, or SAT) and populations at risk for TB infection; and
  • Determine the incidence of active disease and the prevalence of latent TB infection in a specific population.

Click here for more information on Tuberculosis, including how and when to report a case and other disease guidance.

Click here to download the latest report of TB activity in a printable format.

Tuberculosis Case Counts

PDPH TB Counts 2017 - 2022

Philadelphia TB Case Count, 2006-2016

PDPH TB Incidence 2017 - 2022

Philadelphia TB Cases by Race and Ethnicity, 2011-2016

TB Cases by Age Group, 2016

TB Cases in Pennsylvania, 2016

Foreign and U.S. Born Cases

US Born vs Foreign Born Cases of TB in Philadelphia: 2006-2016

Philadelphia Foreign Born TB Cases by WHO Region: 2016

Proportion of Drug Resistance in Positive Culture Cases with Drug Sensitivity Testing: 2011-2016

Risk Factors and Disease Sites

Sites of Disease (TB): 2016

Percentage of Common Risk Factors Among TB Patients: 2016